{"id":"W4389504875","doi":"10.1093/jnci/djad240","title":"Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355","year":2023,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Merck","keywords":"Medicine; Pembrolizumab; Carboplatin; Internal medicine; Breast cancer; Chemotherapy; Quality of life (healthcare); Gemcitabine; Placebo; Oncology; Cancer; Clinical endpoint; Clinical trial; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001127327,0.0004681504,0.00143319,0.0002389421,0.0002186513,0.0005547355,0.0004104733,0.0005963342,0.004129126],"category_scores_gemma":[0.0009028091,0.0001983543,0.0009789566,0.0003034753,0.000394724,0.0004977821,0.0003572874,0.001291896,0.0003491146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006191626,"about_ca_system_score_gemma":0.0007228457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005290419,"about_ca_topic_score_gemma":0.0009865349,"domain_scores_codex":[0.9996698,0.0001320615,0.00003742778,0.0000703122,0.00003824821,0.0000521208],"domain_scores_gemma":[0.9995616,0.0001177913,0.0001210776,0.00002209057,0.00001966167,0.0001577748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9375808,0.009684355,0.003007366,0.0007139069,0.0008584393,0.00003710876,0.0000656263,0.0008190781,0.007133656,0.0001247732,0.0008975911,0.03907733],"study_design_scores_gemma":[0.3939069,0.5534735,0.0426473,0.0001779974,0.002151275,0.0001660039,0.00009700181,0.001871759,0.003240878,0.0002997338,0.001931226,0.0000363789],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958192,0.002255368,0.0001047605,0.0001614092,0.00008222158,0.0003374531,0.0003251002,0.00001497489,0.0008994275],"genre_scores_gemma":[0.9969968,0.0009291891,0.0002911983,0.0002223954,0.00007110862,0.0005027548,0.0004487929,0.000002507164,0.0005353372],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004129126,"threshold_uncertainty_score":0.01381326,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05189114606179587,"score_gpt":0.3683793049925059,"score_spread":0.3164881589307101,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}